 PARIS CAMBRIDGE, Mass.--BUSINESS WIRE--- NBTX NBTX--Regulatory News: NANOBIOTIX Paris:NANO NASDAQ:NBTX Euronext : NANO NASDAQ: NBTX the Company, a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational progress and cash position for the first quarter of 2021. The first quarter of this year saw further progress in development for Nanobiotix, said Laurent Levy, co-founder and chie 